Inogen (INGN) Gross Profit Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 7.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.20% |
| Dec 31, 2025 | 6.14% |
| Sep 30, 2025 | -1.17% |
| Jun 30, 2025 | -3.68% |
| Mar 31, 2025 | 1.28% |
| Dec 31, 2024 | -2.03% |
| Sep 30, 2024 | -4.65% |
| Jun 30, 2024 | -5.31% |
| Mar 31, 2024 | -4.83% |
| Dec 31, 2023 | -6.15% |
| Sep 30, 2023 | 0.76% |
| Jun 30, 2023 | 1.30% |
| Mar 31, 2023 | -7.13% |
| Dec 31, 2022 | -4.58% |
| Sep 30, 2022 | -0.40% |
| Jun 30, 2022 | -2.70% |
| Mar 31, 2022 | -7.62% |
| Dec 31, 2021 | -3.97% |
| Sep 30, 2021 | -0.77% |
| Jun 30, 2021 | 1.27% |
| Mar 31, 2021 | 1.86% |
| Dec 31, 2020 | 3.46% |
| Sep 30, 2020 | -0.17% |
| Jun 30, 2020 | 1.23% |
| Mar 31, 2020 | 14.22% |
| Dec 31, 2019 | 11.17% |
| Sep 30, 2019 | 19.90% |
| Jun 30, 2019 | 24.19% |
| Mar 31, 2019 | 27.79% |
| Dec 31, 2018 | 29.55% |
| Sep 30, 2018 | 36.07% |
| Jun 30, 2018 | 32.53% |
| Mar 31, 2018 | 33.04% |
| Dec 31, 2017 | 30.57% |
| Sep 30, 2017 | 31.31% |
| Jun 30, 2017 | 27.83% |
| Mar 31, 2017 | 29.20% |
| Dec 31, 2016 | 34.37% |
| Sep 30, 2016 | 37.61% |
| Jun 30, 2016 | 33.34% |
| Mar 31, 2016 | 37.89% |